Epoch Investment Partners Inc. Acquires 12,167 Shares of Chemed Co. (NYSE:CHE)

Epoch Investment Partners Inc. lifted its holdings in Chemed Co. (NYSE:CHE) by 5.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 252,237 shares of the company’s stock after purchasing an additional 12,167 shares during the period. Epoch Investment Partners Inc. owned 1.68% of Chemed worth $133,635,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. UMB Bank n.a. lifted its position in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Atala Financial Inc bought a new position in shares of Chemed in the 4th quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC lifted its holdings in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after purchasing an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new stake in Chemed during the fourth quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC boosted its position in Chemed by 77.3% during the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after purchasing an additional 34 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.1 %

Shares of NYSE CHE opened at $580.52 on Friday. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The company has a market cap of $8.48 billion, a P/E ratio of 29.33, a P/E/G ratio of 2.15 and a beta of 0.49. The business’s 50 day moving average is $585.78 and its two-hundred day moving average is $567.83.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is currently 10.05%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on CHE shares. Royal Bank of Canada boosted their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the company’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now owns 101,679 shares of the company’s stock, valued at approximately $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.